PANoptosis-based HNSCPAN-index predicts prognosis and reveals DSCAM as a therapeutic target in head and neck squamous cell carcinoma. Feng Y, Zhang Y, Ou H, Tang Q, et al. PLoS One 2026;21:e0344957.

Read + Share

Amedeo Smart

Independent Medical Education

Read + Share

Feng Y, Zhang Y, Ou H, Tang Q, et al. PANoptosis-based HNSCPAN-index predicts prognosis and reveals DSCAM as a therapeutic target in head and neck squamous cell carcinoma. PLoS One 2026;21:e0344957.
PMID: 42743206